165 related articles for article (PubMed ID: 30895871)
1. Improving dispersal of therapeutic nanoparticles in the human body.
Limongi T; Canta M; Racca L; Ancona A; Tritta S; Vighetto V; Cauda V
Nanomedicine (Lond); 2019 Apr; 14(7):797-801. PubMed ID: 30895871
[No Abstract] [Full Text] [Related]
2. Formation of the Protein Corona: The Interface between Nanoparticles and the Immune System.
Barbero F; Russo L; Vitali M; Piella J; Salvo I; Borrajo ML; Busquets-Fité M; Grandori R; Bastús NG; Casals E; Puntes V
Semin Immunol; 2017 Dec; 34():52-60. PubMed ID: 29066063
[TBL] [Abstract][Full Text] [Related]
3. Biodegradable inorganic nanoparticles: an opportunity for improved cancer therapy?
Li L; Liu H
Nanomedicine (Lond); 2017 May; 12(9):959-961. PubMed ID: 28440705
[No Abstract] [Full Text] [Related]
4. Interplay between nanomedicine and protein corona.
Yang M; Wu E; Tang W; Qian J; Zhan C
J Mater Chem B; 2021 Sep; 9(34):6713-6727. PubMed ID: 34328485
[TBL] [Abstract][Full Text] [Related]
5. Protein Corona Formation on Colloidal Polymeric Nanoparticles and Polymeric Nanogels: Impact on Cellular Uptake, Toxicity, Immunogenicity, and Drug Release Properties.
Obst K; Yealland G; Balzus B; Miceli E; Dimde M; Weise C; Eravci M; Bodmeier R; Haag R; Calderón M; Charbaji N; Hedtrich S
Biomacromolecules; 2017 Jun; 18(6):1762-1771. PubMed ID: 28511014
[TBL] [Abstract][Full Text] [Related]
6. Recent advancements in biocompatible inorganic nanoparticles towards biomedical applications.
Jiao M; Zhang P; Meng J; Li Y; Liu C; Luo X; Gao M
Biomater Sci; 2018 Mar; 6(4):726-745. PubMed ID: 29308496
[TBL] [Abstract][Full Text] [Related]
7. Concentration-dependent protein adsorption at the nano-bio interfaces of polymeric nanoparticles and serum proteins.
Zhang TX; Zhu GY; Lu BY; Zhang CL; Peng Q
Nanomedicine (Lond); 2017 Nov; 12(22):2757-2769. PubMed ID: 29017387
[TBL] [Abstract][Full Text] [Related]
8. Coating nanoparticles with tunable surfactants facilitates control over the protein corona.
Müller J; Bauer KN; Prozeller D; Simon J; Mailänder V; Wurm FR; Winzen S; Landfester K
Biomaterials; 2017 Jan; 115():1-8. PubMed ID: 27871002
[TBL] [Abstract][Full Text] [Related]
9. The nanoparticle protein corona formed in human blood or human blood fractions.
Lundqvist M; Augustsson C; Lilja M; Lundkvist K; Dahlbäck B; Linse S; Cedervall T
PLoS One; 2017; 12(4):e0175871. PubMed ID: 28414772
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticle-protein complexes mimicking corona formation in ocular environment.
Jo DH; Kim JH; Son JG; Dan KS; Song SH; Lee TG; Kim JH
Biomaterials; 2016 Dec; 109():23-31. PubMed ID: 27648757
[TBL] [Abstract][Full Text] [Related]
11. Effect of nanoparticle size and PEGylation on the protein corona of PLGA nanoparticles.
Partikel K; Korte R; Stein NC; Mulac D; Herrmann FC; Humpf HU; Langer K
Eur J Pharm Biopharm; 2019 Aug; 141():70-80. PubMed ID: 31082511
[TBL] [Abstract][Full Text] [Related]
12. Temperature-Triggered Protein Adsorption on Polymer-Coated Nanoparticles in Serum.
Koshkina O; Lang T; Thiermann R; Docter D; Stauber RH; Secker C; Schlaad H; Weidner S; Mohr B; Maskos M; Bertin A
Langmuir; 2015 Aug; 31(32):8873-81. PubMed ID: 26209261
[TBL] [Abstract][Full Text] [Related]
13. Biocompatible polymersomes-based cancer theranostics: Towards multifunctional nanomedicine.
Mohammadi M; Ramezani M; Abnous K; Alibolandi M
Int J Pharm; 2017 Mar; 519(1-2):287-303. PubMed ID: 28115259
[TBL] [Abstract][Full Text] [Related]
14. The "sweet" side of the protein corona: effects of glycosylation on nanoparticle-cell interactions.
Wan S; Kelly PM; Mahon E; Stöckmann H; Rudd PM; Caruso F; Dawson KA; Yan Y; Monopoli MP
ACS Nano; 2015 Feb; 9(2):2157-66. PubMed ID: 25599105
[TBL] [Abstract][Full Text] [Related]
15. Protein-Cloaked Nanoparticles for Enhanced Cellular Association and Controlled Pathophysiology
Dar AI; Abidi SMS; Randhawa S; Joshi R; Kumar R; Acharya A
ACS Appl Mater Interfaces; 2022 Jan; 14(1):337-349. PubMed ID: 34969244
[TBL] [Abstract][Full Text] [Related]
16. Theranostic Approach for the Protein Corona of Polysaccharide Nanoparticles.
Skalickova S; Horky P; Mlejnkova V; Skladanka J; Hosnedlova B; Ruttkay-Nedecky B; Fernandez C; Kizek R
Chem Rec; 2021 Jan; 21(1):17-28. PubMed ID: 33274843
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle-Protein Interaction: The Significance and Role of Protein Corona.
Ahsan SM; Rao CM; Ahmad MF
Adv Exp Med Biol; 2018; 1048():175-198. PubMed ID: 29453539
[TBL] [Abstract][Full Text] [Related]
18. Self-Assembled Lipid Nanoparticles for Oral Delivery of Heparin-Coated Iron Oxide Nanoparticles for Theranostic Purposes.
Truzzi E; Bongio C; Sacchetti F; Maretti E; Montanari M; Iannuccelli V; Vismara E; Leo E
Molecules; 2017 Jun; 22(6):. PubMed ID: 28598368
[TBL] [Abstract][Full Text] [Related]
19. Cancer Nano-Immunotherapy from the Injection to the Target: The Role of Protein Corona.
Mikelez-Alonso I; Aires A; Cortajarena AL
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947622
[TBL] [Abstract][Full Text] [Related]
20. Mesoporous Silica and Organosilica Nanoparticles: Physical Chemistry, Biosafety, Delivery Strategies, and Biomedical Applications.
Croissant JG; Fatieiev Y; Almalik A; Khashab NM
Adv Healthc Mater; 2018 Feb; 7(4):. PubMed ID: 29193848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
